Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
- PMID: 19252145
- DOI: 10.1192/bjp.bp.107.048827
Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Abstract
Background: In spite of the growing literature about adult attention-deficit hyperactivity disorder (ADHD), relatively little is known about the prevalence and correlates of this disorder.
Aims: To estimate the prevalence of adult ADHD and to identify its demographic correlates using meta-regression analysis.
Method: We used the MEDLINE, PsycLit and EMBASE databases as well as hand-searching to find relevant publications.
Results: The pooled prevalence of adult ADHD was 2.5% (95% CI 2.1-3.1). Gender and mean age, interacting with each other, were significantly related to prevalence of ADHD. Meta-regression analysis indicated that the proportion of participants with ADHD decreased with age when men and women were equally represented in the sample.
Conclusions: Prevalence of ADHD in adults declines with age in the general population. We think, however, that the unclear validity of DSM-IV diagnostic criteria for this condition can lead to reduced prevalence rates by underestimation of the prevalence of adult ADHD.
Comment in
-
Review: prevalence of adult ADHD declines with age.Evid Based Ment Health. 2009 Nov;12(4):128. doi: 10.1136/ebmh.12.4.128-a. Evid Based Ment Health. 2009. PMID: 19854790 No abstract available.
Similar articles
-
Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands.Br J Psychiatry. 2012 Oct;201(4):298-305. doi: 10.1192/bjp.bp.111.101196. Epub 2012 Aug 9. Br J Psychiatry. 2012. PMID: 22878132
-
Clinical correlates of oppositional defiant disorder and attention-deficit/hyperactivity disorder in adults.Postgrad Med. 2011 Mar;123(2):177-84. doi: 10.3810/pgm.2011.03.2276. Postgrad Med. 2011. PMID: 21474906
-
Gender differences in adult attention-deficit/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).J Clin Psychiatry. 2016 Apr;77(4):e421-8. doi: 10.4088/JCP.14m09630. J Clin Psychiatry. 2016. PMID: 27137426
-
Gender differences in adults with attention-deficit/hyperactivity disorder: A narrative review.Clin Psychol Rev. 2015 Aug;40:15-27. doi: 10.1016/j.cpr.2015.05.005. Epub 2015 May 27. Clin Psychol Rev. 2015. PMID: 26046624 Review.
-
Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256 Suppl 1:i3-11. doi: 10.1007/s00406-006-1001-7. Eur Arch Psychiatry Clin Neurosci. 2006. PMID: 16977549 Review.
Cited by
-
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study.Neuropsychiatr Dis Treat. 2013;9:211-8. doi: 10.2147/NDT.S35836. Epub 2013 Feb 8. Neuropsychiatr Dis Treat. 2013. PMID: 23430373 Free PMC article.
-
Clinical, Psychopathological, and Personality Characteristics Associated with ADHD among Individuals Seeking Treatment for Gambling Disorder.Biomed Res Int. 2015;2015:965303. doi: 10.1155/2015/965303. Epub 2015 Jul 1. Biomed Res Int. 2015. PMID: 26229967 Free PMC article. Clinical Trial.
-
Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study.BMC Psychiatry. 2020 Oct 2;20(1):485. doi: 10.1186/s12888-020-02867-8. BMC Psychiatry. 2020. PMID: 33008345 Free PMC article. Clinical Trial.
-
Potential Targets and Action Mechanism of Gastrodin in the Treatment of Attention-Deficit/Hyperactivity Disorder: Bioinformatics and Network Pharmacology Analysis.Evid Based Complement Alternat Med. 2022 Sep 12;2022:3607053. doi: 10.1155/2022/3607053. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36133787 Free PMC article.
-
Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.CNS Drugs. 2015 Aug;29(8):683-93. doi: 10.1007/s40263-015-0264-9. CNS Drugs. 2015. PMID: 26267739 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical